"This is the first of seven studies that we're doing to study this medicine," he expanded, "the oral GLP-1 inhibitor that we've been developing for more than eight years. And the results are ...

Department of Pharmacy, the Second Affiliated Hospital of Wannan Medical College, Wuhu 241000, China Research Center of Integration of Traditional Chinese and Western Medicine, Wannan Medical College, ...

Novartis has terminated a phase 2 trial evaluating an investigational ADAMTS-5 inhibitor for patients with osteoarthritis knee pain. The Big Pharma company discontinued the study testing intra ...

Here, we describe a “beads-on-a-string” (BOAS) immunogen, that tandemly links up to eight distinct hemagglutinin (HA) head domains from circulating and non-circulating influenzas. These BOAS are ...

Treatment with delgocitinib cream, a topical pan-Janus kinase inhibitor, resulted in a significant improvement in health-related quality of life in patients with moderate to severe chronic hand ...

Two proteins, the "H" and the "N" ones, stud the virus's exterior. H stands for hemagglutinin: It sticks to a cell's sugars so the virus can gain entry. N is for neuraminidase: It allows newborn ...

The presentation highlighted tolebrutinib’s potential as the first Bruton’s tyrosine kinase (BTK) inhibitor to receive regulatory approval for the treatment of progressive MS. During the Clinical ...

Salt Lake City, UT, April 08, 2025 (GLOBE NEWSWIRE) -- Recursion (Nasdaq: RXRX), a leading clinical stage TechBio company decoding biology to radically improve lives, today announced that the ...